Amy Kontorovich, MD Email Amy Kontorovich
- ASSISTANT PROFESSOR | Medicine, Cardiology
- Cardiovascular Disease
- Hospital Affiliation
- The Mount Sinai Hospital
- The Lauder Family Cardiovascular Center 212-241-9004 212-241-9004
Book an Appointment - Amy Kontorovich, MD
Amy Rosen Kontorovich, MD, PhD is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai in the Division of Cardiology and is the Medical Director of Adult Cardiovascular Genetics in the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josee and Henry R. Kravis Center for Cardiovascular Health of the Mount Sinai Medical Center. Dr. Kontorovich received a B.S.E in Bioengineering from the University of Pennsylvania and M.D. and Ph.D. degrees through the esteemed Medical Scientist Training Program of the National Institutes of Health at Stony Brook University. Her doctoral work was recognized by the United States Patent and Trademark Office, which named her a finalist in the National Collegiate Inventor’s Competition and Dr. Kontorovich holds two US patents for tracking stem cells with quantum dot nanoparticles.
Dr. Kontorovich completed the Internal Medicine residency at the Icahn School of Medicine at Mount Sinai, where she also completed the fellowship in Cardiology. During fellowship she engaged in specialized training in clinical genetics and conducted research on the genetics of viral myocarditis, an inflammatory condition of the heart that can lead to sudden cardiac death and cardiomyopathy. Her research was recognized by the New York Academy of Medicine, which awarded her the prestigious Glorney-Raisbeck Fellowship in Cardiovascular Diseases.
Dr. Kontorovich’s clinical practice is focused on the diagnosis and management of individuals with heritable cardiovascular conditions including vascular connective tissue disorders and aortopathies, cardiomyopathies, channelopathies and sudden cardiac death. As Medical Director of Adult Cardiovascular Genetics, Dr. Kontorovich is part of the leadership of Mount Sinai Heart’s Cardiovascular Genetics Program:
Clinical focus areas include:
• Aortic aneurysm
• Vascular connective tissue disorders (including Marfan syndrome, Loeys-Dietz syndrome and Ehlers-Danlos syndrome)
• Other aneurysm and/or dissections
• Hereditary hemorrhagic telangiectasia
• Hypertrophic cardiomyopathy
• Dilated cardiomyopathy
• Arrhythmogenic cardiomyopathies
• Familial rhythm disorders (including Long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia and sudden cardiac death)
• Familial hyperlipidemia
American Board of Internal Medicine
American Board of Internal Medicine
MD, Stony Brook University Medical Center
PhD, Stony Brook University Medical Center
Residency, Internal Medicine
Mount Sinai Hospital
Mount Sinai School of Medicine
Research topics Myocarditis, cardiomyopathy, genetics of cardiovascular diseases
Dr. Kontorovich’s research is focused on finding genetic factors that influence development of myocarditis. Myocarditis, most often caused by viral infection, is associated with considerable morbidity and mortality in adults and children, causing more than 10% of cases of dilated cardiomyopathy and sudden cardiac death in adults. Little is known about the pathogenesis of viral infection or replication in human myocardium. Cardiotropic viruses are quite common in the environment, yet most infected individuals have no apparent clinical manifestations and the vast majority never develops myocarditis. Human genetic variation is therefore likely important in the phenotypic evolution of myocarditis and may determine the fate of disease in infected individuals. Hence, Dr. Kontorovich is investigating genetic factors that underlie predilection to myocarditis through experiments using human induced pluripotent stem cells, sophisticated gene editing techniques (CRISPR technology), as well as human genomic studies on patients with myocarditis.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Kontorovich during 2018 and/or 2019. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Alnylam Pharmaceuticals
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.